The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4global Regulatory News (4GBL)

Share Price Information for 4global (4GBL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 50.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 5.00 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 52.50
4GBL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Purchase / PDMR Dealing

12 Jul 2022 07:00

RNS Number : 0892S
4GLOBAL PLC
12 July 2022
 

12 July 2022

4Global plc

("4Global" or the "Company")

Director Share Purchase / PDMR Dealing

The Company has today been notified that Maeda Cinco S.L., a company in which the Company's Chief Executive Eloy Mazon has an interest, purchased on 8 July and 11 July 2022 a total of 53,000 Ordinary Shares of 1p each in the Company at an average price of 70.12 pence per share.

Following these transactions, Eloy Mazon has a beneficial interest in a total of 13,423,517 Ordinary Shares, (13,304,017 in his own name and 119,000 in Maeda Cinco S.L.) representing, in aggregate, 50.95 per cent. of the Company's issued ordinary share capital.

The notification below, made in accordance with the Market Abuse Regulation, provides further details in relation to the purchase of Ordinary Shares.

NOTIFICATIONS AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Eloy Mazon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (Executive Director)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

4Global Plc

b)

 

LEI

 

 

89450099YF5FU8P84Z25

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB00BLH36N37

 

b)

 

Nature of the transaction

 

 

Purchase of ordinary shares by Maeda Cinco S.L., a company in which Mr Mazon has a beneficial interest.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

On 8 July 2022:

 

 

On 11 July 2022:

69.9p

70.0p

 

69.8p

69.82p

70.25p

71.70p

10,000

5,000

 

7,500

7,500

20,000

3,000

 

 

 

d)

 

Aggregated information

- Aggregated volume

On 8 July 2022 - 15,000 shares at an average price of 69.93p

On 11 July 2022 - 38,000 shares at an average price of 70.19p

Total - 53,000 shares at an average price of 70.12p

- Total Price

e)

 

Date(s) of the transaction

 

 

8 July 2022 and 11 July 2022

f)

 

Place of the transaction

 

 

AIMX

 

**ENDS**

For further information please contact:

4GLOBAL

c/o IFC Advisory

Eloy Mazon (CEO)

 

 

Spark Advisory Partners - Nominated Adviser

0203 368 3554

Neil Baldwin

 

 

Oberon Capital - Broker

0203 179 5300

Michael Seabrook, Adam Pollock, Chris Crawford

 

 

IFC Advisory

 

0203 934 6630

Graham Herring / Zach Cohen

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAPXFFLAAEFA
Date   Source Headline
15th May 20247:00 amRNSTrading Update
8th May 20242:38 pmRNSNotification of Major Holdings
23rd Apr 20248:00 amRNSIssue of share options
22nd Apr 20247:00 amRNSCorrection: Holding(s) in Company
22nd Apr 20247:00 amRNSDirectorate Changes
17th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20244:17 pmRNSIssue of share options
11th Mar 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSDirectorate Change
22nd Jan 20245:14 pmRNSBoard Change
16th Jan 20247:00 amRNSContract Wins
7th Dec 20237:00 amRNSInterim Results
15th Nov 20237:00 amRNSContract Extension
17th Oct 20237:00 amRNSContract Wins
27th Sep 202312:11 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
13th Sep 20237:00 amRNSArtificial Intelligence and Machine Learning Trial
30th Aug 20237:00 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
15th Jun 202310:42 amRNSHolding(s) in Company
24th May 20237:00 amRNSPartnership agreement with Technogym UK
17th May 20237:00 amRNSStrategic partnership in North America
11th May 20237:00 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSChange of Broker
27th Apr 20237:00 amRNSTrading Update
13th Feb 20235:51 pmRNSAIM Rule 17 Notification
6th Feb 20231:58 pmRNSPCA Share Purchase / PDMR Dealing
21st Dec 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSSports Event Contract Win
31st Oct 20227:00 amRNS4GLOBAL secures £4M contract win
3rd Oct 20223:30 pmRNSDirectorate Change
15th Sep 20227:00 amRNS4GLOBAL and EuropeActive launch global datahub
8th Sep 202212:59 pmRNSResult of AGM
8th Sep 20227:00 amRNSBusiness Update
8th Aug 20228:53 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSDirector Share Purchase / PDMR Dealing
7th Jul 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
4th Jul 20227:00 amRNSNotice of results & investor presentation
24th May 20224:45 pmRNSDirector Share Purchase / PDMR Dealing
17th May 20223:54 pmRNSDirector Share Purchase / PDMR Dealing
31st Mar 20227:00 amRNSAppointment of Chief Customer Officer
17th Mar 20227:00 amRNSTrading Update and Contract Wins
3rd Feb 20227:00 amRNSFitness Industry Council of Canada Partnership
17th Jan 20227:00 amRNSLaunch of new Social Value Calculator
29th Dec 202110:26 amRNSHolding(s) in Company
21st Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSNew Contract Win
7th Dec 20217:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.